OWLO provides real-time, non-invasive 3D microscopy powered by AI image analysis for healthcare applications. Their technology aims to improve embryo selection in Assisted Reproductive Technologies by providing new indicators of viability before implantation. This allows for more effective procedures and reduced costs.
Funding
Funding not disclosed
AFounders
Product
Problem
Current microscopy techniques for healthcare applications often involve invasive procedures and may not provide real-time, three-dimensional imaging of biological tissues. This can limit the ability to assess tissue viability and make informed clinical decisions, particularly in sensitive areas like in vitro fertilization and ophthalmology.
Solution
OWLO provides a non-invasive, real-time 3D microscopy solution powered by AI image analysis. Their technology utilizes a module compatible with standard microscopes, employing an intelligent illumination sequence to capture detailed information from samples. Advanced algorithms based on wave physics process and display 3D images with high resolution, even deep within tissues. The system generates unique data, enabling the extraction of specific biomarkers for healthcare applications and enhancing the reliability of clinical decisions.
Target Audience
The primary users are biologists and clinicians in fields such as in vitro fertilization and ophthalmology, as well as researchers in drug discovery.
Features
- Non-invasive 3D microscopy for real-time imaging
- Module compatible with any standard microscope
- Intelligent illumination sequence for detailed data capture
- Advanced algorithms based on wave physics for 3D image processing
- AI-powered analysis for biomarker extraction
- Applications in in-vitro fertilization (IVF), drug discovery, and ophthalmology